Characterisation and expression of a large, 13.7 kb FMR2 isoform.

FMR2 is the gene associated with FRAXE fragile site non-specific mental retardation (FRAXE MRX). Previously a male patient was identified with developmental delay and speech problems who had a deletion within intron 3 of FMR2. No known FMR2 exonic sequences were missing in this patient. Detailed northern blot analysis revealed existence of a new large isoform of FRM2 in foetal brain. This isoform was characterised and found to be due entirely to an addition of an extra 4.9 kb of the 3′ UTR to the previously characterised 8.755 kb FMR2 transcript. This excluded involvement of the large FMR2 isoform in the MRX phenotype of three individuals now known to have the same deletion of intron 3 FMR2 sequences. Expression studies on the new 13.7 kb FMR2 isoform show that it is expressed predominantly in foetal brain and adult pituitary gland, whilst the expression of the shorter previously characterised 8.755 kb isoform is broader, including testis, thymus and placenta. Possible consequences of the alternative processing and expression of FMR2 for the molecular pathology of FRAXE MRX are discussed.

[1]  K. Davies,et al.  Expression of the murine homologue of FMR2 in mouse brain and during development. , 1998, Human molecular genetics.

[2]  S. Antonarakis,et al.  Mind the GAP, Rho, Rab and GDI , 1998, Nature Genetics.

[3]  J. Dantonel,et al.  Transcription factor TFIID recruits factor CPSF for formation of 3′ end of mRNA , 1997, Nature.

[4]  C. Walsh,et al.  PAK3 mutation in nonsyndromic X-linked mental retardation , 1998, Nature Genetics.

[5]  H. Alder,et al.  The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene , 1992, Cell.

[6]  J. Gécz,et al.  Gene structure and subcellular localization of FMR2, a member of a new family of putative transcription activators. , 1997, Genomics.

[7]  J. Richter.  17 Dynamics of Poly(A) Addition and Removal during Development , 1996 .

[8]  H. R. Crollius,et al.  Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation , 1998, Nature.

[9]  E. Haan,et al.  FMR2 expression in families with FRAXE mental retardation. , 1997, Human molecular genetics.

[10]  L. Staudt,et al.  LAF-4 encodes a lymphoid nuclear protein with transactivation potential that is homologous to AF-4, the gene fused to MLL in t(4;11) leukemias. , 1996, Blood.

[11]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[12]  J. Gécz,et al.  Identification of the gene FMR2, associated with FRAXE mental retardation , 1996, Nature Genetics.

[13]  A. Korneyev.  The Role of the Hypothalamic–Pituitary–Adrenocortical Axis in Memory-Related Effects of Anxiolytics , 1997, Neurobiology of Learning and Memory.

[14]  Andrea Menegon,et al.  Mutations in GDI1 are responsible for X-linked non-specific mental retardation , 1998, Nature Genetics.

[15]  G. Seydoux.  Mechanisms of translational control in early development. , 1996, Current opinion in genetics & development.

[16]  R. Gibbs,et al.  Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island , 1996, Nature Genetics.

[17]  K. Davies,et al.  A candidate gene for mild mental handicap at the FRAXE fragile site. , 1996, Human molecular genetics.

[18]  J. Gécz,et al.  Cloning and expression of the murine homologue of a putative human X-linked nuclear protein gene closely linked to PGK1 in Xq13.3. , 1994, Human molecular genetics.

[19]  J. Gécz,et al.  Overlapping submicroscopic deletions in Xq28 in two unrelated boys with developmental disorders: identification of a gene near FRAXE. , 1995, American journal of human genetics.

[20]  J. Frestedt,et al.  AF4/FEL, a gene involved in infant leukemia: sequence variations, gene structure, and possible homology with a genomic sequence on 5q31. , 1996, DNA and cell biology.